Agency Business briefs: December 2013

Share this article:
Agency Business briefs: December 2013
Agency Business briefs: December 2013

Mid-size strategic communications firm Cooney/Waters and PR company Russo Partners have merged to create Clearpath Health Communications. The staff is comprised of scientists, physicians, marketers and former journalists.

The Federal Trade Commission says Publicis and Omnicom can merge. AdAge reports that Europe and China still need to approve, but “the frenemies seem to be aligning chess pieces in media, creative and digital.”

Boutique agency Incubate has launched new division Incubate Health and ushered in a rebranded Incubate.com. The three-year-old agency's site is part of a push to broaden its digital services and includes case studies and a news and trends blog.

AdAge highlights the latest wave in Pharma non-marketing marketing. One example: the Lilly-Disney site Spoonful.com which combines diabetes education and community interaction. Partners provide “playful branded stories, games and tips,” to help young patients. Parents are also hooked. AdAge notes one mom used the community to talk about how her son turned checking his sugar levels into a Fantasy Football competition.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?